UPMC- RxAnte, a leading provider of solutions that improve the use of prescription medications, announced today that it has received a growth equity investment from UPMC Enterprises. Under the terms of the transaction closed on Sept. 30, Millennium Health sold its entire interest in RxAnte, which will continue to operate as an independent company, led by its existing management team.
Explore Our Insights
Read More
UPMC Enterprises Invests in Ouro Medicines to Advance New Autoimmune Therapies Through T-Cell Engagers and B-Cell Depletion
UPMC Enterprises Demonstrates its Community Commitment Through Support of Pittsburgh Economy
